Stay up to date with the latest developments in urinary biomarkers for bladder cancer and UTUC. Explore educational articles, scientific reviews, expert commentaries, and clinical cases covering emerging evidence and evolving approaches to detection and surveillance.
Reviewed by Mr. Hugh Mostafid “As EpiCheck® results are remarkable, this assay is now included in the diagnostic work-up of UTUC at our center.” [1] Urothelial carcinomas are most commonly found in...
Reviewed by Professor Jørgen Bjerggaard Jensen (Aarhus University Hospital, Aarhus, Denmark) “A strategy alternating the urine marker Bladder EpiCheck® with cystoscopy in the surveillance of...
Urinary biomarkers: Are we prepared to replace cystoscopies? Watch the webinar presentations by Dr. Fernando Lozano and Dr. Alberto Breda On June 7, 2021, HM Hospitales (Spain) organised the webinar...
David is a 71-year-old amateur golfer. Despite the closing of the golf club due to the COVID-19 pandemic, he enjoys playing a game in his 8 square meter garden using a miniature golf set. He was...
Which biomarker metric is dependent on disease prevalence, and therefore cannot be compared between different cohorts? Submit your answer and read the opinion of Mr. Hugh Mostafid. *...
May is Bladder Cancer Awareness Month. We need you to create awareness! The World Bladder Cancer Patient Coalition hosts this special month to highlight the facts about bladder cancer, promote...